Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
Neima Briggs, Michael V. Gormally, Fangyong Li, Sabrina L. Browning, Miriam M. Treggiari, Alyssa Morrison, Maudry Laurent-Rolle, Yanhong Deng, Jeanne E. Hendrickson, Christopher A. Tormey, Mahalia S. Desruisseaux
doi: https://doi.org/10.1101/2021.06.16.21258972
Neima Briggs
aDepartment of Medicine, Yale School of Medicine, New Haven, CT
MD, PhDMichael V. Gormally
aDepartment of Medicine, Yale School of Medicine, New Haven, CT
MD, PhDFangyong Li
bYale Center for Analytical Sciences, Yale University, New Haven CT
MPH, MSSabrina L. Browning
cSection of Hematology, Department of Medicine, Yale School of Medicine and Yale Cancer Center, New Haven CT
MDMiriam M. Treggiari
dDepartment of Anesthesiology, Yale School of Medicine, New Haven, CT
MD, PhD, MPHAlyssa Morrison
eYale School of Medicine, New Haven, CT
Maudry Laurent-Rolle
fSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT
MD, PhDYanhong Deng
bYale Center for Analytical Sciences, Yale University, New Haven CT
MPHJeanne E. Hendrickson
gDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, CT
hDepartment of Pediatrics, Yale School of Medicine, New Haven, CT
MDChristopher A. Tormey
gDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, CT
MDMahalia S. Desruisseaux
fSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT
MDData Availability
All data contained herein are available accordingly.
Posted June 18, 2021.
Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
Neima Briggs, Michael V. Gormally, Fangyong Li, Sabrina L. Browning, Miriam M. Treggiari, Alyssa Morrison, Maudry Laurent-Rolle, Yanhong Deng, Jeanne E. Hendrickson, Christopher A. Tormey, Mahalia S. Desruisseaux
medRxiv 2021.06.16.21258972; doi: https://doi.org/10.1101/2021.06.16.21258972
Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
Neima Briggs, Michael V. Gormally, Fangyong Li, Sabrina L. Browning, Miriam M. Treggiari, Alyssa Morrison, Maudry Laurent-Rolle, Yanhong Deng, Jeanne E. Hendrickson, Christopher A. Tormey, Mahalia S. Desruisseaux
medRxiv 2021.06.16.21258972; doi: https://doi.org/10.1101/2021.06.16.21258972
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)